DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market

Core Insights - Diagnos Inc. has appointed Dr. Tomas J. Philipson to its Advisory Board, enhancing its expertise in healthcare policy and economic strategy [1][7] - The company focuses on early detection of critical eye-related health issues using AI technology, aiming to improve diagnostic accuracy and patient outcomes [8] Company Overview - Diagnos Inc. is a publicly traded Canadian corporation dedicated to leveraging AI for early detection of eye health problems [8] - The company has developed an AI platform that analyzes retina images, which are collected from thousands of optometrists globally [7] Market Potential - In 2020, the US conducted approximately 111 million routine eye exams and 60 million medical eye exams, indicating a significant market opportunity for Diagnos [7] - The recent establishment of a US office in South Florida aims to support the company's growth and client engagement in this expanding market [7] Advisory Board Expertise - Dr. Philipson is recognized for his extensive experience in US economic policy, particularly in healthcare, and has served in various high-level government roles [2][4] - His background includes being a managing partner at MEDA Ventures and co-founding Precision Health Economics LLC, showcasing his entrepreneurial and investment acumen [3][4] Academic and Professional Recognition - Dr. Philipson has received numerous awards in health economics, including the Arrow Award and the Garfield Award for Economic Research, highlighting his contributions to the field [5] - He holds advanced degrees in mathematics and economics from prestigious institutions, further solidifying his expertise [6]